[The Code As Witness Is A Book About Science, Politics And Pandemic Inquiry](https://wbbsec.com/opinions-and-features/dr-steve-brozak-reviews-the-code-as-witness-in-forbes/)
[The Code As Witness Is A Book About Science, Politics And Pandemic Inquiry](https://wbbsec.com/opinions-and-features/dr-steve-brozak-reviews-the-code-as-witness-in-forbes/)
  •   (858) 592-9901
  •   [email protected]
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute

Opinions & Features

The U.S. is at a Kasserine Pass moment for Covid leaders

By:WBB SecuritiesPosted: Dec 9th, 2021In: Opinions & Features, SARS-CoV-2

In the military, as in business and civilian life, leadership change can be needed to achieve victory or solve a problem. That’s where the U.S. is today with Covid-19.

Read More about The U.S. is at a Kasserine Pass moment for Covid leaders

Two Years Into Covid-19 And What Are The Real Omicron Surprises.

By:WBB SecuritiesPosted: Dec 1st, 2021In: Opinions & Features, SARS-CoV-2

Today, the Covid-19 pandemic will have raged for two years and we are still confronting surprises...

Read More about Two Years Into Covid-19 And What Are The Real Omicron Surprises.

Covid-19 Just Voted And It Will Vote Again In 2022

By:WBB SecuritiesPosted: Nov 8th, 2021In: Opinions & Features, SARS-CoV-2

With apologies to the Sunday morning talk show commentators, any explanation for the November 2 election results other than Covid-19 must be labelled incidental...

Read More about Covid-19 Just Voted And It Will Vote Again In 2022

What Today’s CDC Covid-19 Vaccine Panel Needs To Confront

By:WBB SecuritiesPosted: Oct 21st, 2021In: Opinions & Features, SARS-CoV-2

Last night’s US Food and Drug Administration (FDA) announcement approving Moderna and Johnson & Johnson’s Covid-19 boosters, and the simultaneous endorsement of the mixing of vaccines with boosters from all three approved manufacturers, sets the[...]

Read More about What Today’s CDC Covid-19 Vaccine Panel Needs To Confront

FDA And Pfizer Need A Covid-19 Reality Booster

By:WBB SecuritiesPosted: Sep 18th, 2021In: Opinions & Features, SARS-CoV-2

Friday’s FDA Vaccines and Related Biological Products (VRBPAC) meeting on Pfizer’s Covid-19 vaccine booster... 

Read More about FDA And Pfizer Need A Covid-19 Reality Booster

Novavax’s Manufacturing Issues Are Solvable, But Covid-19 Vaccine Herd Immunity May Not Be

By:WBB SecuritiesPosted: Aug 6th, 2021In: Opinions & Features

In the last 24-hours vaccine makers, Moderna and Novavax both released positive....

Read More about Novavax’s Manufacturing Issues Are Solvable, But Covid-19 Vaccine Herd Immunity May Not Be

Unmasking The Covid Realities – The CDC Still Needs To Find The Data

By:WBB SecuritiesPosted: May 14th, 2021In: Opinions & Features

Mark Twain famously said: Get your facts first, and then you can distort them as much as you please....

Read More about Unmasking The Covid Realities – The CDC Still Needs To Find The Data

Courage: A Book About Life And Beating The Odds In Healthcare.

By:WBB SecuritiesPosted: Apr 5th, 2021In: Opinions & Features

Courage: A Book About Life And Beating The Odds In Healthcare...

Read More about Courage: A Book About Life And Beating The Odds In Healthcare.

AstraZeneca, Data Collection, And Covid-19 Irrational Exuberance

By:WBB SecuritiesPosted: Mar 23rd, 2021In: Opinions & Features

“Late Monday, the Data and Safety Monitoring Board notified NIAID, BARDA, and AstraZeneca...

Read More about AstraZeneca, Data Collection, And Covid-19 Irrational Exuberance

It Will Take The G-7 To Stop Covid-19: Here Are 5 Reasons Why.

By:WBB SecuritiesPosted: Feb 19th, 2021In: Opinions & Features

During today’s G-7 virtual meetings, President Joseph Biden announced the commencement of delivery on $4 Billion in Congressionally approved Covid-19 global aid.

Read More about It Will Take The G-7 To Stop Covid-19: Here Are 5 Reasons Why.
Load More

Recent News

  • Dr. Steve Brozak Reviews The Code as Witness in Forbes June 9, 2026
  • Deaths, Burned Clinics—What’s Different About Ebola’s 2026 Return? – Published in Forbes May 25, 2026
  • 5 Urgent Questions After The WHO Emergency Hantavirus Meeting – Published in Forbes May 15, 2026
  • Our Mental Health Crisis: RFK Jr. Faces Psychiatric Over-Prescribing – Published in Forbes May 6, 2026
  • WBB Securities President Dr. Steve Brozak to Moderate ARPA-H Panel at Biotech Showcase 2026 on Federal Investment in Biotech Innovation January 12, 2026

20 Commerce Dr.
Ste. 135
Cranford, NJ 07016

3111 Camino Del Rio N.
Ste. 400
San Diego, CA 92108

Copyright © 2026 WBB Securities, LLC. All Rights Reserved. Member FINRA/SIPC, BrokerCheck

  • Form CRS
  • Disclosures
  • Privacy Policy
Menu Bottom